Real-time enrollment status for this liver cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:32 AM UTC
| NCT Number | NCT05797805 |
| Recruiting Status | Recruiting |
| Condition | Liver Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 178 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Iterion Therapeutics |
| Last Updated on CT.gov | July 4, 2025 (Jul 4, 2025) |
As of March 2, 2026: Clinical trial NCT05797805 is currently recruiting participants. This clinical trial study for liver cancer is actively seeking new participants at 7 locations across the United States. The study is sponsored by Iterion Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05797805 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05797805 was last updated Jul 4, 2025 (July 4, 2025). HelloStudys verifies this status automatically.